SPDS 09052014
Phosphodiesterase Type 5 (PDE5) Inhibitors
• Used in the treatment of erectile dysfunction (ED) and also explored for the treatment of pulmonary hypertension • Block degradative action of PDE5 on cyclic guanosine monophosphate (cGMP) in smooth muscle cells lining the blood vessels supplying the corpus cavernosum of the penis (and arterial walls within the lungs)
cGMP
• cGMP = second messenger relaxing smooth muscle tissues, leading to the increased blood flow in blood vessels
PDE5 Inhibitors – Mechanism of Action
cGMP
Made with FlippingBook